{"entity":{"id":"nobelpharma","kind":"company","name":"Nobelpharma","aka":["Nobelpharma Co., Ltd.","ノーベルファーマ"],"tldr":"Nobelpharma is a Tokyo company founded in 2003 to develop medicines for rare diseases and unmet needs in Japan, including cancer treatments it takes through phase 3 trials.","summary":"Nobelpharma Co., Ltd., based in Chūō, Tokyo, was founded in 2003 to bring medicines for rare diseases and unmet medical needs to the Japanese market, often licensing products approved elsewhere and running the Japanese trials needed for approval. It is lead sponsor of several phase 3 cancer trials registered on ClinicalTrials.gov.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.nobelpharma.co.jp"},{"label":"ClinicalTrials.gov: trials led by Nobelpharma","url":"https://clinicaltrials.gov/search?lead=Nobelpharma"},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q11325922"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Tokyo","country":"JP","companyType":"pharma","website":"https://www.nobelpharma.co.jp","founded":2003,"stage":"private-large","investors":[],"funding":[]},"route":"/companies/nobelpharma/","neighbours":{}}